Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3692860012 | Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3692861011 | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 46767501000001113 | Fusidic acid 2% / Betamethasone valerate 0.1% cream | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| 60129601000001115 | Betamethasone valerate 0.1% / Fusidic acid 2% cream | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Is a | Product containing betamethasone and fusidic acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Betamethasone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Adrenal hormone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Corticosterone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Adrenal hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Fusidic acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Conventional release cutaneous cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Is a | Product containing fusidic acid in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has precise active ingredient | Fusidic acid | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has precise active ingredient | Betamethasone valerate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has basis of strength substance | Fusidic acid | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has concentration strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has basis of strength substance | Betamethasone | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Is a | Product containing betamethasone valerate in topical dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has concentration strength numerator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Is a | Product containing only betamethasone and fusidic acid in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Betamethasone valerate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Betamethasone | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Conventional release cutaneous cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | cream.cutaneous ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Continuous dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Topical route | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Is a | Betamethasone + Fusidic acid | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Fusidic acid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Cutaneous | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Conventional release cutaneous cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Betamethasone valerate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Conventional release cutaneous cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Betamethasone | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has specific active ingredient | Fusidic acid | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has specific active ingredient | Betamethasone valerate | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has dispensed dose form | Cream | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Has basis of strength substance | Betamethasone | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Betamethasone+fusidic acid 0.1/2% cream - product | Is a | False | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Fucibet cream (LEO Pharma) | Is a | True | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Fucibet cream (PI) (Dowelhurst Ltd) | Is a | True | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Fucibet cream (DE Pharmaceuticals) | Is a | True | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Fucibet cream (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Fusidic acid 2% / Betamethasone valerate 0.1% cream 60 gram | Is pack of | False | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Fusidic acid 2% / Betamethasone valerate 0.1% cream 30 gram | Is pack of | False | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Fucibet Lipid cream (LEO Pharma) | Is a | True | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Fusidic acid 2% / Betamethasone valerate 0.1% cream 60 gram | Has VMP | True | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Fusidic acid 2% / Betamethasone valerate 0.1% cream 30 gram | Has VMP | True | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Xemacort 20mg/g / 1mg/g cream (Viatris UK Healthcare Ltd) | Is a | True | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Betamethasone valerate 0.1% / Fusidic acid 2% cream (A A H Pharmaceuticals Ltd) | Is a | False | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and fusidic acid 20 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR